An MRA is recommended for patients with persisting symptoms (NYHA Class II–IV) and an EF ≤35% despite therapy with an ACE inhibitor (or ARB) and a beta-blocker (Class I; Level A recommendation) Ensure ...
Doctors are reassessing decades of standard treatment for patients who have had heart attacks after new research shows beta-blockers may be anywhere from useless to harmful in certain cases. The ...
Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...
Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern ...
A drug costing less than 2 euros per dose could reduce the long term consequences of a heart attack, benefitting millions of patients. Metoprolol, a member of the beta-blocker class of drugs that has ...
These blood-pressure-lowering drugs can calm the rapid heartbeat, shaky voice and trembling hands that can wreck a ...
A drug costing less than 2 euros per dose could reduce the long term consequences of a heart attack, benefitting millions of patients. Metoprolol, a member of the beta-blocker class of drugs that has ...
Two new studies point in opposite directions. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide ...
NEW YORK (Reuters Health) - Unlike earlier beta-blocker drugs used to treat high blood pressure, the newer drug carvedilol does not cause weight gain in people with diabetes, according to findings ...
Depression was not more common in patients who used beta-blockers. The rate of discontinuing medications due to depression was the same for people taking beta-blockers compared to people taking other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback